¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : 2015ÄêÉñ¾­ÉúÎïѧ¿¼²©ÖªÊ¶µã
¼¶±ð: ÂÛ̳°æÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2015-02-08   

2015ÄêÉñ¾­ÉúÎïѧ¿¼²©ÖªÊ¶µã

Ãû´Ê½âÊÍ W~QH"Sq  
:=J^"c  
1¡¢Í»´¥µçλ£ºÉñ¾­µÝÖÊ´ÓÍ»´¥Ç°Ä¤Í¨¹ý°ûÍÂ×÷ÓÃÊÍ·Å£¬¿ç¹ýÍ»´¥¼ä϶£¬×÷ÓÃÓÚÍ»´¥ºóÄ££¬ÔÚµçÉúÀíÑо¿ÉÏ£¬¿ÉÒԹ۲쵽ͻ´¥ºóÄ£ÉÏÒýÆðÒ»¸ö¶ÌÔݵصçλ±ä»¯¡£°üÀ¨EPSPÓëIPSP¡£ w9W0j  
\{RMj"w:  
À©Õ¹£ºÍ»´¥synapse Éñ¾­ÔªÓëÉñ¾­ÔªÖ®¼äµÄ»úÄÜÁ¬½Óµã¡£ RY4b <i3  
p[J 8 r{'  
2¡¢Epsp:ÐË·ÜÐÔÍ»´¥ºóµçλ(Excitatory Postsynaptic Potential,EPSP)ÊǵÝÖÊÒýÆðµÄÍ»´¥ºóĤµÄ¶ÌÔÝÈ¥¼«»¯¡£EPSPÊÇÓɶÔNa+ºÍK+¶¼Í¨Í¸µÄ¹È°±ËáÃÅ¿ØÀë×ÓͨµÀ¿ª·ÅËùÐγɡ£ M `=bJO:  
9td[^EB#(h  
¹È°±ËáÃÅ¿ØÀë×ÓͨµÀ½éµ¼Á½ÖÖ²»Í¬Ê±³ÌµÄEPSC(ExcitatoryPostsynaptic Current) ' thEZ  
n-5@<y^  
AMPA/KAÊÜÌåͨµÀ½éµ¼¿ìʱ³ÌµÄEPSC iYE7BUH=  
pT ;{05  
NMDAÊÜÌåͨµÀ½éµ¼Âýʱ³ÌµÄEPSC 5'mpd  
hHoc>S6^M  
IPSP:ÒÖÖÆÐÔÍ»´¥ºóµçλ(Inhibitory Postsynaptic Potential,IPSP)ÊǵÝÖÊÒýÆðµÄÍ»´¥ºóĤµÄ¶ÌÔݳ¬¼«»¯. @TWtM#  
CB1AL]|3  
IPSPÊÇÓɶÔCl-ͨ͸µÄGABAºÍGlycineÃÅ¿ØÀë×ÓͨµÀ¿ª·ÅËùÐγɡ£ f]*_]J/  
Jm5&6=  
3¡¢SynapseÍ»´¥£ºµçÍ»´¥(Electrical Synapse)ºÍ»¯Ñ§ÐÔÍ»´¥(Chemical Synapse)£¬µ«ÒÔ»¯Ñ§ÐÔÍ»´¥ÎªÖ÷¡£µçÍ»´¥Í¨¹ý·ì϶Á¬½Ó(gapjunction)Ö±½ÓÍê³Éϸ°û¼äµÄµçÐÅÏ¢´«µÝ¡£»¯Ñ§ÐÔÍ»´¥´«µÝ±ØÐëÒÀÀµÓÚÉñ¾­µÝÖÊ(Neurotransmitters)»òÉñ¾­ëÄ(Neuropeptides)×÷ÓÃÓÚÍ»´¥ºóĤµÄÊÜÌå¶øÍê³Éϸ°û¼äµÄÐÅÏ¢´«µÝ¡£ -2`D(xC  
4
¡¢Action potential¶¯×÷µçλ£ºÊÇ´¦ÓÚ¾²Ï¢µçλ״̬µÄϸ°ûĤÊܵ½Êʵ±´Ì¼¤¶ø²úÉúµÄ£¬Ë²¼äʹ°ûÄÚµçλÏà¶ÔÓÚ°ûÍâΪÕýµçλ¡£ÊÇÒ»´Î¿ÉÄæµÄ¡¢¿É´«µ¼µÄµçλ±ä»¯ @[vwqPOL  
UojHlTg#bT  
Àë×Ó»ù´¡£ºµçѹÃÅ¿ØÄÆÍ¨µÀ½á¹¹ &E{i#r)'T  
sA}Xha  
Ó°Ï춯×÷µçλ´«µ¼µÄÒòËØ£ºÖáÍ»´Öϸ£»ÖáÍ»ÉÏÄÆÍ¨µÀµÄÃܶȣ»ËèÇʺÍÌøÔ¾´«µ¼¡£ .0eHP  
;Bs^+R7  
¶¯×÷µçλËù¾ßÓеÄÌØÐÔµÄÒâÒå:ÏÞÖÆ´«µ¼ÆµÂÊ;²»»á·¢ÉúÖØµþ×ܺÍ;²»»áÔÚϸ°û±íÃæÀ´»ØÍù¸´Õñµ´¡£ rP=!!fC1;  
$:aKb#l)  
Resting potential¾²Ï¢µçλ£ºÉñ¾­ÔªÎ´Êܴ̼¤Ê±´æÔÚÓÚϸ°ûĤÄÚÍâÁ½²àµÄµçλ²î¡£ <r1N6(n  
5
¡¢Electroencephhy-EEGÄÔµçͼ£ºÊǽ«ÄÔϸ°ûµÄ×Ô·¢·Åµç»î¶¯Í¨¹ýµç×Ó·Å´óÆ÷·Å´ó²¢Ãè¼ÇÔÚÖ½ÉϵÄÒ»Öֿ͹ۼǼ´óÄÔ»úÄÜ״̬µÄ¼ì²é·½·¨¡£ÊÇÒ»ÖÖÎÞ´´ÆÀ¼Û·½·¨¡£ y9>?  
4 <&8`Q  
7¡¢Éñ¾­µ÷ÖÊ(Neuromodulator) £ºÓÐһЩÉñ¾­µ÷½ÚÎï±¾Éí²¢²»Ö±½Ó´¥·¢ËùÖ§Åäϸ°ûµÄ¹¦ÄÜЧӦ£¬Ö»Êǵ÷ÖÆ´«Í³µÝÖʵÄ×÷Óᣠx9Qa.Jmj  
eL7rX"!  
¿ÉΪÉñ¾­Ï¸°û¡¢½ºÖÊϸ°û»òÆäËü·ÖÃÚϸ°ûËùÊÍ·Å£¬¶ÔÖ÷µÝÖÊÆðµ÷ÖÆ×÷Óᣠ@6~OQN  
u\]aUP e  
±¾Éí²»Ö±½Ó¸ºÔð¿çÍ»´¥ÐźŴ«µÝ»ò²»Ö±½ÓÒýÆðЧӦϸ°ûµÄ¹¦Äܸı䣬¶øÊǵ÷½ÚÐÅÏ¢´«µÝµÄЧÂÊ£¬ÔöÇ¿»òÏ÷ÈõµÝÖʵÄЧӦ¡£ YnCWmlC  
k/|j e~$  
¼ä½Óµ÷ÖÆÖ÷µÝÖÊÔÚÍ»´¥Ç°Éñ¾­Ä©ÉÒµÄÊͷż°Æä»ù´¡»î¶¯Ë®Æ½¡£  1aAYBV<3  
S(5aJ[7Zm  
Ó°ÏìÍ»´¥ºóЧӦϸ°û¶ÔµÝÖʵķ´Ó¦ÐÔ£¬¶ÔµÝÖʵÄЧӦÆðµ÷ÖÆ×÷ÓᣠBU| bo")  
j+p=ik  
8¡¢ÀÄÓÃ(Abuse)Ö¸Ò»ÖÖ·ÇÒ½ÁÆËùÐèµÄ²»Á¼ÓÃÒ©·½Ê½£¬ÓÉÓÚ·´¸´Ê¹ÓÃÒ©Îïµ¼ÖÂÁËÃ÷ÏԵIJ»Á¼ºó¹û£¬Èç²»ÄÜÍê³ÉÖØÒªµÄ¹¤×÷¡¢Ñ§Òµ£¬Ëðº¦ÁËÇûÌå¡¢ÐÄÀí½¡¿µ£¬µ¼Ö·¨ÂÉÉϵÄÎÊÌâµÈ¡£ 'x-PQQ  
9=-!~ _'1-  
9¡¢ÄÍÊÜÐÔ(Tolerance)Ö¸Ò©ÎïʹÓÃÕß±ØÐëÔö¼Ó¼ÁÁ¿·½ÄÜ»ñµÃËùÐèµÄЧ¹û£¬ÈçÈÔÒÔÔ­À´µÄ¼ÁÁ¿Ôò´ï²»µ½Ëù×·ÇóµÄЧ¹û¡£ 8+b ?/Rn0  
LAoX'^6  
10¡¢¶¯»úMotivation£ºÖ¸ÐÐΪÆð¶¯Ç°Éñ¾­¸ß¼¶²¿Î»ÄÇÖÖÓëµ¼Ö¸ÃÐÐΪ·¢ÉúÓйصÄ˼ά»î¶¯£¬ÊÇÒâÏò¡¢Çý¶¯µÄ¾ÛºÏ£¬Ëü×îÖÕµ¼ÖÂÐÐΪµÄ³öÏÖ¡£ L'>t:^QTh  
P9wx`x""k  
11¡¢½ä¶Ï×ÛºÏÖ¢£¨withdrawal syndrome£© u/@dWeY[]  
|VC/ (A  
ָֹͣʹÓÃÒ©Îï»ò¼õÉÙʹÓÃÒ©Îïºó»òʹÓÃÞ׿¹¼ÁºóËù³öÏÖµÄÌØÊâµÄÐÄÀíÉúÀí֢״Ⱥ¡£²»Í¬µÄÒ©ÎïËùÖµĽä¶ÏÖ¢×´ÒòÆäÒ©ÀíÌØÐÔ²»Í¬¶øÒ죬һ°ã±íÏÖΪËùʹÓÃÒ©ÎïµÄÒ©Àí×÷ÓÃÏà·´µÄÖ¢×´¡£ÀýÈç±½±û°·ÀàÐ˷ܼÁÒÀÀµ½ä¶Ïºó³öÏÖÎÞÁ¦¡¢Ë¼Ë¯¡¢ÇéÐ÷ÒÖÓôµÈÖ¢×´£»¶ø¾Æ¾«(ÖÐÊàÉñ¾­ÏµÍ³ÒÖÖÆ¼Á)ÒÀÀµ½ä¶Ïºó³öÏÖÐË·Ü¡¢²»Ãߣ¬ÉõÖÁñ²ðïÑù·¢×÷µÈ±íÏÖ¡£ ">? y\#O A  
#hBDOXHPf  
12¡¢³Éñ«(addiction) @'K+   
TT(d CHft  
50Äê´úÊÀ½çÎÀÉú×é֯ר¼ÒίԱ»á½«Ò©Îï³Éȳ¶¨ÒåΪ£º¡°ÓÉÓÚ·´¸´Ê¹ÓÃijÖÖÒ©ÎïËùÒýÆðµÄÒ»ÖÖÖÜÆÚÐÔ»òÂýÐÔÖж¾×´Ì¬£¬¾ßÓÐÒÔÏÂÌØÕ÷£º¢ÙÓÐÒ»ÖÖ²»¿É¿¹¾ÜµÄÁ¦Á¿Ç¿ÖÆÐÔµØÇýʹÈËÃÇʹÓøÃÒ©£¬²¢²»ÔñÊÖ¶ÎÈ¥»ñµÃËü£»¢ÚÓмӴó¼ÁÁ¿µÄÇ÷ÊÆ£»¢Û¶Ô¸ÃÒ©µÄЧӦ²úÉú¾«ÉñÒÀÀµ£¬Ò²¿É²úÉúÇûÌåÒÀÀµ£»¢Ü¶Ô¸öÈ˺ÍÉç»á¶¼²úÉúΣº¦¡£ÓÉÓÚ¡°³Éñ«¡±ÕâÒ»ÊõÓïÓÃ;̫¿í·º£¬ÊÀ½çÎÀÉú×éÖ¯½¨ÒéÓá°ÒÀÀµ¡±À´´úÌæ¡°³Éñ«¡±¡£ ;t R,w   
<3!jra,h  
Growth cone£ºÉñ¾­ÔªÖáÍ»ºÍÊ÷Í»Éú³¤µÄÄ©¶Ë±»³ÆÎªÉú³¤×µ¡££¬ÊÇÒ»Öָ߶ÈÄܶ¯µÄϸ°û½á¹¹ÌØ»¯ÐÎʽ£¬³Ê±¡µÄ±âƽĤ״£¬Éì³öһЩϸ³¤µÄ˿״α×ã×÷ΪÆäÑÓÉ첿·Ö---¼¡¶¯µ°°×¡£ e/?>6'6 5  
UeVRd  
Ras»ùÒò£¬ÊÇÒ»ÖÖÔ­°©»ùÒò£¬ÊÇÕý³£Ï¸°ûÖи߶ȱ£Êصġ°Ï¸°û»ùÒò¡±¡£ËüÓÉÄæ×ªÂ¼²¡¶¾»î»¯ºó¿ÉÒÔת»¯³ÉÓÐÖ°©ÄÜÁ¦µÄ°©»ùÒò¡£ÔÚÕý³£Ï¸°ûÖÐÓÐ3ÖÖrasÔ­°©»ùÒò£¬C-Ha-ras, C-Ki-rasºÍC-N-ras¡£
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
¼¶±ð: ÂÛ̳°æÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
ɳ·¢  ·¢±íÓÚ: 2015-02-08   
1¡¢¼¹Ëè±³½ÇCÏËάµÄÖ÷Ҫͻ´¥µÝÖÊÊÇʲô£¿ÇëÉè¼Æ²»Í¬ÊµÑé·½·¨ÓèÒÔ֤ʵ£¿ 20·Ö p7SX,kpt>  
-@*[   
¼¹Ëè±³½ÇCÏËάÊÇÎÞËèÏËά£¬´«µ¼ÄÚÔà¸Ð¾õ£¨Ö÷ÒªÊÇÍ´¾õ£©¡£ËüµÄÍ»´¥µÝÖÊÊÇPÎïÖÊ£¨substance P£¬SP£©ºÍ¹È°±Ëá£*****lu£©£¬ÕâÁ½ÖÖµÝÖÊ¿ÉÒÔ¹²´æÓÚCÏËάÖС£ÆäÖйȰ±Ëá£*****lu£©ÊÇCÏËάÖÐ×îÖ÷ÒªµÄµÝÖÊ£¬ËüÊÇÒ»ÖÖÐË·ÜÐÔµÝÖÊ¡£ =yT3#A~<G  
(i3V  
ʵÑé·½·¨·½Ã棬ÎÒ²»ÔÚÐУ¬Ö®Ç°Ò»Ö±´ÓÊÂÁÙ´²¹¤×÷¡£ÌáµãСµÄ½¨Ò飬ϣÍû¶ÔÂ¥Ö÷ÓÐËùÆô·¢£ºÈç¹ûÖªµÀÄ¿µÄµÝÖÊÊǹȰ±ËᣬӦ¸Ã¿ÉÒÔÓÃÃâÒßÓ«¹â±ê¼ÇÀ´¶Ô¹È°±Ëá½øÐж¨ÐÔ¡¢¶¨Á¿·ÖÎö¡£ CdB sd  
W~" 'a9H/  
2¡¢p75NTR ÊÜÌåÓëTrksÊÜÌ干ͬ±í´ïµÄÒâÒå£¨Ôø¾­¿¼Ì⣩20·Ö XSfl'Fll D  
9^yf'9S1  
ÎÒ¶ÔÕâ·½Ãæ²»Á˽⡣ /-C`*P=:u  
.~3s~y*s  
3¡¢ÖÐÊàÉñ¾­ÏµÍ³·¢ÓýµÄÌØµã¼°ÌØÕ÷¡£20·Ö z2.9l?"rfQ  
^4G%*-   
ÖÐÊàÉñ¾­ÏµÍ³¾ÍÊÇÄԺͼ¹Ë裬ËùÒÔÕâÌâ¾ÍÊÇÎÊÄԺͼ¹Ëè·¢ÓýµÄÌØµãºÍÌØÕ÷¡£Õâ¸öÎÊÌâÈç¹ûÕÒ²»µ½±ê×¼´ð°¸£¬ÄÇô¾ÍÐèÒª×Ô¼º×ܽᡣÎÒÍÆ¼öÁ½±¾Ê飬¡¶Éñ¾­½âÆÊѧ¡·½¯ÎÄ»ªÖ÷±à£¬¸´µ©´óѧ³ö°æÉ磨Õâ±¾ÊéÍøÉÏÓеç×Ó°æµÄ£¬×Ô¼ºËÑһϣ¬Ãâ·ÑµÄ£©¡£ÁíÍâÒ»±¾¾ÍÊÇ¡¶×éÖ¯Åß̥ѧ¡·½Ì²Ä¡£ÕâÁ½±¾Êé¶¼¶ÔÄԺͼ¹Ëè·¢ÓýÓÐ×ÅÏêϸµÄÃèÊö¡£¶à¿´¼¸±é£¬¾ÍÖªµÀ·¢Óý¹ý³ÌÖÐÓÐÄö¹Ø¼üµã£¬¹Ø¼üµã¾ÍÊÇÌØµãÂ±ÈÈç˵ÄԵķ¢Óý£ºÉñ¾­¹ÜÍ·¶ËÐγÉÈý¸öÄÔÅÝ£¨µÚÒ»¸ö¹Ø¼üµÄµØ·½£©£¬ÄÔÅÝÏȺó³öÏÖ¼¸¸öÍäÇú£¨µÚ¶þ¸ö¹Ø¼üµÄµØ·½£©£ºÏȳöÏÖÍ·Çú£¬È»ºó³öÏÖ¾±Çú£¬×îºó³öÏÖÄÔÇÅÇú¡£¡£¡£¡£¡£¡£
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»